Literature DB >> 9769832

Nonossifying fibroma: characteristics at MR imaging with pathologic correlation.

W H Jee1, B Y Choe, H S Kang, K J Suh, J S Suh, K N Ryu, Y S Lee, I Y Ok, J M Kim, K H Choi, K S Shinn.   

Abstract

PURPOSE: To correlate the findings of nonossifying fibroma at magnetic resonance (MR) imaging with those at pathologic examination.
MATERIALS AND METHODS: In 19 patients (age range, 8-25 years; mean age, 14 years) with pathologically proved nonossifying fibroma, MR images were analyzed for signal intensity and patterns of contrast enhancement. Findings at MR imaging and biopsy were correlated.
RESULTS: On T1-weighted images, all nonossifying fibromas had low signal intensity compared with that of skeletal muscle. On T2-weighted images, 15 lesions (79%) were hypointense and four (21%) were hyperintense. On gadolinium-enhanced images, intense contrast enhancement was seen throughout 15 lesions (heterogeneous pattern in 12 and homogeneous in three) and in the margins and septa in four. Extensive hypercellular fibrous tissue and hemosiderin seen at pathologic examination were depicted with low signal intensity on T2-weighted MR images.
CONCLUSION: The distinguishing features of nonossifying fibroma included hypointensity and septation on T2-weighted images. Signal intensity on T1- and T2-weighted MR images and the patterns of contrast enhancement were dependent on the amounts of hypercellular fibrous tissue, hemosiderin, hemorrhage, collagen, foamy histiocytes, and bone trabeculae.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769832     DOI: 10.1148/radiology.209.1.9769832

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  Characterization of pediatric skeletal tumors and tumor-like conditions: specific cross-sectional imaging signs.

Authors:  Laura M Fayad; David A Bluemke; Kristin L Weber; Elliot K Fishman
Journal:  Skeletal Radiol       Date:  2006-03-15       Impact factor: 2.199

Review 2.  Pitfalls in paediatric musculoskeletal imaging.

Authors:  Christian J Kellenberger
Journal:  Pediatr Radiol       Date:  2009-06

3.  Surgical treatment for symptomatic non-ossifying fibromas of the lower extremity with calcium sulfate grafts in skeletally immature patients.

Authors:  Antonio Andreacchio; Flavia Alberghina; Gianluca Testa; Federico Canavese
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-08-17

Review 4.  MRI of the knee: key points in the pediatric population.

Authors:  Peter J Strouse
Journal:  Pediatr Radiol       Date:  2010-04

5.  68Ga DOTA-TOC Uptake in Non-ossifying Fibroma: a Case Report.

Authors:  Aysar Khalaf; Nader Hirmas; Farah Anwer; Akram Al-Ibraheem
Journal:  Nucl Med Mol Imaging       Date:  2020-07-06

Review 6.  Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review.

Authors:  Henry J Mankin; Carol A Trahan; Gertrud Fondren; Carole J Mankin
Journal:  Chir Organi Mov       Date:  2009-04-29

7.  MR findings of the osteofibrous dysplasia.

Authors:  Joon-Yong Jung; Won-Hee Jee; Sung Hwan Hong; Heung Sik Kang; Hye Won Chung; Kyung-Nam Ryu; Jee-Young Kim; Soo-A Im; Jeong-Mi Park; Mi-Sook Sung; Yeon-Soo Lee; Suk-Joo Hong; Chan-Kwon Jung; Yang-Guk Chung
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

8.  Pitfalls in the diagnosis of common benign bone tumours in children.

Authors:  Dana I Dumitriu; Renaud Menten; Philippe Clapuyt
Journal:  Insights Imaging       Date:  2014-09-26

9.  Nonossifying fibroma: A possible pitfall in F18-FD-PET/CT imaging of Hodgkin's disease.

Authors:  Manuela Pagano; Mara Berta; Anna Maria Postini; Maurizio Bianchi; Adalberto Brach Del Prever; Claudio Defilippi; Umberto Ficola; Angelina Cistaro
Journal:  Radiol Case Rep       Date:  2015-11-06

Review 10.  The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions.

Authors:  F Alyas; S L James; A M Davies; A Saifuddin
Journal:  Eur Radiol       Date:  2007-03-07       Impact factor: 7.034

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.